The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-α
Abstract
TNF-α mediates both protective and detrimental manifestations of the host immune response. Our previous work has shown thalidomide to be a relatively selective inhibitor of TNF-α production in vivo and in vitro. Additionally, we have recently reported that thalidomide exerts a costimulatory effect on T cell responses. To develop thalidomide analogues with increased anti-TNF-α activity and reduced or absent toxicities, novel TNF-α inhibitors were designed and synthesized. When a selected group of these compounds was examined for their immunomodulatory activities, different patterns of cytokine modulation were revealed. The tested compounds segregated into two distinct classes: one class of compounds, shown to be potent phosphodiesterase 4 inhibitors, inhibited TNF-α production, increased IL-10 production by LPS-induced PBMC, and had little effect on T cell activation; the other class of compounds, similar to thalidomide, were not phosphodiesterase 4 inhibitors and markedly stimulated T cell proliferation and IL-2 and IFN-γ production. These compounds inhibited TNF-α, IL-1β, and IL-6 and greatly increased IL-10 production by LPS-induced PBMC. Similar to thalidomide, the effect of these agents on IL-12 production was dichotomous; IL-12 was inhibited when PBMC were stimulated with LPS but increased when cells were stimulated by cross-linking the TCR. The latter effect was associated with increased T cell CD40 ligand expression. The distinct immunomodulatory activities of these classes of thalidomide analogues may potentially allow them to be used in the clinic for the treatment of different immunopathological disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,677
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Mueller, D. L., Jenkins, M. K., & Schwartz, R. H. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.002305 · Cited by 1,493
Kindler, V., Sappino, A.-P., Grau, G. E., Piguet, P.-F., & Vassalli, P. (1989) · Cell · doi:10.1016/0092-8674(89)90676-4 · Cited by 1,254
Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., & Gately, M. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1223 · Cited by 1,197
Tumour necrosis factors α and β inhibit virus replication and synergize with interferons
Wong, G. H. W., & Goeddel, D. V. (1986) · Nature · doi:10.1038/323819a0 · Cited by 713
Haslett, P. A. J., Corral, L. G., Albert, M., & Kaplan, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.11.1885 · Cited by 573
Self-citationHamuryudan, V., Mat, C., Saip, S., Ozyazgan, Y., Siva, A., Yurdakul, S., Zwingenberger, K., & Yazici, H. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-6-199803150-00004 · Cited by 456
Impaired interleukin 12 production in human immunodeficiency virus-infected patients.
Chehimi, J., Starr, S. E., Frank, I., D'Andrea, A., Ma, X., MacGregor, R. R., Sennelier, J., & Trinchieri, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1361 · Cited by 419
Coughlin, C. M., Salhany, K. E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A. E., Hunter, C. A., Fox, J. C., Trinchieri, G., & Lee, W. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1555 · Cited by 415
Restoration of HIV-Specific Cell-Mediated Immune Responses by Interleukin-12 in Vitro
Clerici, M., Lucey, D. R., Berzofsky, J. A., Pinto, L. A., Wynn, T. A., Blatt, S. P., Dolan, M. J., Hendrix, C. W., Wolf, S. F., & Shearer, G. M. (1993) · Science · doi:10.1126/science.7903123 · Cited by 384
Antiviral effects of recombinant tumour necrosis factor in vitro
Mestan, J., Digel, W., Mittnacht, S., Hillen, H., Blohm, D., Möller, A., Jacobsen, H., & Kirchner, H. (1986) · Nature · doi:10.1038/323816a0 · Cited by 383
Sampaio, E. P., Kaplan, G., Miranda, A., Nery, J. A. C., Miguel, C. P., Viana, S. M., & Sarno, E. N. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/168.2.408 · Cited by 366
Self-citationAmino-substituted thalidomide analogs: Potent inhibitors of TNF-α production
Muller, G. W., Chen, R., Huang, S.-Y., Corral, L. G., Wong, L. M., Patterson, R. T., Chen, Y., Kaplan, G., & Stirling, D. I. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00250-4 · Cited by 341
Self-citationHanifin, J. M., Chan, S. C., Cheng, J. B., Tofte, S. J., Henderson, W. R., Kirby, D. S., & Weiner, E. S. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12297888 · Cited by 229
Histamine inhibits the production of interleukin-12 through interaction with H2 receptors.
van der Pouw Kraan, T. C., Snijders, A., Boeije, L. C., de Groot, E. R., Alewijnse, A. E., Leurs, R., & Aarden, L. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3692 · Cited by 207
Eigler, A., Siegmund, B., Emmerich, U., Baumann, K. H., Hartmann, G., & Endres, S. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.1.101 · Cited by 187
Muller, G. W., Corral, L. G., Shire, M. G., Wang, H., Moreira, A., Kaplan, G., & Stirling, D. I. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9603328 · Cited by 158
Self-citationSelection of Novel Analogs of Thalidomide with Enhanced Tumor Necrosis Factor α Inhibitory Activity
Corral, L. G., Muller, G. W., Moreira, A. L., Chen, Y., Wu, M., Stirling, D., & Kaplan, G. (1996) · Molecular Medicine · doi:10.1007/bf03401909 · Cited by 155
Self-citationTsenova, L., Sokol, K. A., Freedman, V. H., & Kaplan, G. (1998) · The Journal of Infectious Diseases · doi:10.1086/515327 · Cited by 153
Self-citationPrabhakar, U., Lipshutz, D. B., Bartus, J. O., Slivjak, M. J., Smith, E. F., Lee, J. C., & Esser, K. M. (1994) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(94)90054-x · Cited by 135
Beneficial effects of tumour necrosis factor-alpha (TNF-α) blockade in rheumatoid arthritis (RA)
Maini, R. N., Elliott, M. J., Brennan, F. M., & Feldmann, M. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb08340.x · Cited by 135
Sekut, L., Yarnall, D. P., Stimpson, S. A., Noel, L. S., BATEMAN-FITE, R., Clark, R., Brackeen, M. F., Menius, J. A., & Connolly, K. M. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03613.x · Cited by 128
DeKruyff, R. H., Gieni, R. S., & Umetsu, D. T. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.359 · Cited by 99
Takenaka, H., Maruo, S., Yamamoto, N., Wysocka, M., Ono, S., Kobayashi, M., Yagita∥, H., Okumura, K., Hamaoka, T., Trinchieri, G., et al. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.1.80 · Cited by 99
Nakajima, A., Kodama, T., Morimoto, S., Azuma, M., Takeda, K., Oshima, H., Yoshino, S., Yagita∥, H., & Okumura, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1901 · Cited by 90
Marriott, J. B., Westby, M., Cookson, S., Guckian, M., Goodbourn, S., Muller, G. W., Shire, M. G., Stirling, D., & Dalgleish, A. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4236 · Cited by 89
Self-citationPosavad, C. M., Koelle, D. M., & Corey, L. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8165-8168.1996 · Cited by 86
Tracey, K. J., & Cerami, A. (1992) · Experimental Biology and Medicine · doi:10.3181/00379727-200-43426 · Cited by 85
Thalidomide Stimulates T Cell Responses and Interleukin 12 Production in HIV-Infected Patients
Haslett, P. A. J., Klausner, J. D., Makonkawkeyoon, S., Moreira, A. L., Metatratip, P., Boyle, B., Kunachiwa, W., Maneekarn, N., Vongchan, P., Corral, L. G., et al. (1999) · AIDS Research and Human Retroviruses · doi:10.1089/088922299310269 · Cited by 83
Self-citationTamir, A., Granot, Y., & Isakov, N. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1514 · Cited by 79
Yoshimura, T., Kurita, C., Nagao, T., Usami, E., Nakao, T., Watanabe, S., Kobayashi, J., Yamazaki, F., Tanaka, H., & Nagai, H. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00580-0 · Cited by 76
Thalidomide analogs and PDE4 inhibition
Muller, G. W., Shire, M. G., Wong, L. M., Corral, L. G., Patterson, R. T., Chen, Y., & Stirling, D. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00475-2 · Cited by 67
Self-citationCrocker, I. C., Townley, R. G., & Khan, M. M. (1996) · Immunopharmacology · doi:10.1016/0162-3109(95)00053-4 · Cited by 61
Suárez, A., Mozo, L., Gayo, A., Zamorano, J., & Gutiérrez, C. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271112 · Cited by 38
Type 4 phosphodiesterase inhibitors and their potential in the treatment of inflammatory disease
de Brito, F., Souness, J. E., & Warne, P. J. (1997) · Emerging Drugs · doi:10.1517/14728214.2.1.249 · Cited by 23
Cavanagh, L. L., Barnetson, R. S., Basten, A., & Halliday, G. M. (1997) · International Journal of Cancer · Cited by 13
Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
Hawkey, C. J., & Stack, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380514 · Cited by 7
Cited by
Davies, F. E., Raje, N., Hideshima, T., Lentzsch, S., Young, G., Tai, Y.-T., Lin, B., Podar, K., Gupta, D., Chauhan, D., et al. (2001) · Blood · doi:10.1182/blood.v98.1.210 · Cited by 913
Self-citationEfficacy of Lenalidomide in Myelodysplastic Syndromes
List, A., Kurtin, S., Roe, D. J., Buresh, A., Mahadevan, D., Fuchs, D., Rimsza, L., Heaton, R., Knight, R., & Zeldis, J. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041668 · Cited by 880
Hideshima, T., Chauhan, D., Shima, Y., Raje, N., Davies, F. E., Tai, Y.-T., Treon, S. P., Lin, B., Schlossman, R. L., Richardson, P., et al. (2000) · Blood · doi:10.1182/blood.v96.9.2943 · Cited by 875
Self-citationRichardson, P. G., Schlossman, R. L., Weller, E., Hideshima, T., Mitsiades, C., Davies, F., LeBlanc, R., Catley, L. P., Doss, D., Kelly, K., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0996 · Cited by 804
Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma
Hawrylowicz, C. M., & O'Garra, A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1589 · Cited by 683
Metadata
- Authors
- Corral, L. G., Haslett, P. A. J., Muller, G. W., Chen, R., Wong, L.-M., Ocampo, C. J., Patterson, R. T., Stirling, D. I., & Kaplan, G.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-07-01
- Volume
- 163
- Issue
- 1
- Pages
- 380-386
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W4313376856
- Cited by
- 656
- References
- 38
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.